SBC Medical Group Holdings (SBC) Depreciation & Amortization (CF) (2023 - 2025)

SBC Medical Group Holdings has reported Depreciation & Amortization (CF) for 3 years, with the latest figure at $673684.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 27.68% year-over-year to $673684.0; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 29.35% YoY), and the FY2025 full-year result was $2.7 million, down 29.35% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $673684.0, down from $746211.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $2.6 million in Q4 2023, with the low at $628304.0 in Q1 2025.
• Historically, Depreciation & Amortization (CF) has averaged $1.1 million across 3 years, with a median of $881270.5 in 2024.
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) sank 63.59% — and 2025, when it fell 23.45%.
• SBC Medical Group Holdings' Depreciation & Amortization (CF) stood at $2.6 million in 2023, then slumped by 63.59% to $931596.0 in 2024, then slipped by 27.68% to $673684.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $673684.0 (Q4 2025), $746211.0 (Q3 2025), and $636101.0 (Q2 2025), per Business Quant data.